Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
20806-43-3
93204-37-6
3005-66-1
145881-74-9
19645-29-5
206265-31-8
1228552-02-0 | Bendamustine Ether Impurity | AA009JIU | MFCD29039589
1250999-20-2 | 2-Bromo-5,6-dihydro-8h-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester | AA009JZU | MFCD11035864
113948-00-8 | 2-(2-Bromophenyl)-2-methylpropanoic acid | AA009LS5 | MFCD11036927
1024-57-3 | Epoxyheptachlor | AA009NHM | MFCD00168030
103882-84-4 | gemcitabine | AA009OSV | MFCD00869720
10019-68-8 | DESMOSINE STANDARD | AA009R1H | MFCD12910449
113276-96-3 | valilactone | AA009UDG | MFCD12032161
1373233-09-0 | 8-Bromoimidazo[1,2-a]pyridin-6-amine, HCl | AA009W26 | MFCD22192409
1345471-93-3 | 5-Bromo-6-fluoro-1-isopropyl-1,2,3-benzotriazole | AA009WI0 | MFCD20441855
135926-94-2 | 4,4'-Dihexyl-2,2'-bithiophene | AA009WMZ | MFCD28386097